This study sought to determine if human immunodeficiency
virus–type 1 (HIV-1) infected depressed men were
more likely to be neuropsychologically impaired than their
nondepressed counterparts. Subjects were 47 HIV-1 infected
men who met DSM–III–R criteria for current
major depressive disorder (MDD) and 47 HIV-1 infected nondepressed
male controls (M age = 34.2 years) equated on
HIV-1 disease severity, demographics, and drug use. The
psychiatric interview included the Structured Clinical
Inventory for the DSM–III–R, and Hamilton Rating
Scale for Depression. The neuropsychological battery included
tests covering 8 functional domains based on an expanded
Halstead-Reitan Battery. The medical assessment included
a history and physical examination, immunologic staging,
and evaluation of prescription and recreational drug use.
Prevalence of global neuropsychological impairment in the
two groups (depressed vs. control) did not differ
[53% vs. 38% respectively; χ2(1,
N = 94) = 2.11, p > .05]. While
syndromically depressed patients performed less well than
nondepressed individuals on memory tests [delayed
retention portions of the Story Memory Test: F(1,91)
= 5.34, p < .05; and Figure Memory Test: F(1,90)
= 4.16, p < .05], the majority of depressed
participants (64%) did not have clinically impaired memory.
No relationship between neuropsychological impairment and
severity of depression was observed. The results suggest
that, while HIV-1 infected men with major depression may
perform more poorly than nondepressed men on some aspects
of memory tasks, they are not more likely to evidence clinically
significant neurocognitive impairment. (JINS,
1997, 3, 457–463.)